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Human Monocyte Chemotaxis: Migrating Cells Are a
Subpopulation with Multiple Chemotaxin Specificities on
Each Cell
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Health, Bethesda, Maryland 20205
Only 20 to 40% of human blood monocytes were capable of responding to
chemotaxins in vitro. This limit is not due to restrictions of the in vitro system,
but is due to the existence of a migrating subpopulation. Over a wide range, the
number of cells migrating toward a given concentration of chemotaxin was
directly proportional to the number added to the chemotaxis chamber. These
monocytes responded to all of the three stimuli used: human serum-derived C5a,
human lymphocyte-derived chemotactic factor, and a synthetic peptide. It was
possible to deactivate cells to one attractant, leaving the response to other
attractants intact. This suggested that these attractants were recognized by
different receptors. Several lines of evidence showed that most migrating cells
had receptors for all three chemotaxins tested. Thus, if cells were assayed for
migration to one attractant, no additional migration occurred when the remaining
cells were assayed for migration to a different attractant. Furthermore, the same
cells that had migrated toward one attractant were able to respond to other
chemotaxins. We also found that a single attractant attracted as many cells as a
combination of two or three attractants. Calculations from these data showed
that at least 75% of the migrating monocytes have different receptors for all three
attractants.
Macrophages play an important role in the
immunological response to neoplasms and are
found at the site of primary and transplanted
tumors. Since peripheral blood monocytes are
precursors of these effector macrophages, the
ability of monocytes to migrate may be essential
for accumulation at tumor sites. Monocytes from
cancer patients have abnormal chemotaxis in
vitro. Decreased monocyte chemotaxis was as-
sociated with poor prognosis (14); the abnormal
response was reversed by surgical removal of the
tumor (13). Boetcher and Leonard showed dif-
ferences in monocyte response to two different
chemotactic agents, lymphocyte derived-chem-
otactic factor (LDCF) and activated serum (6).
Only 50% of cancer patients with impaired re-
sponses to LDCF also had reduced responses to
activated serum. These findings suggest that
either there are specific subpopulations of mi-
grating monocytes with different chemotaxin re-
ceptors or that specific receptors in a homoge-
neous population with multiple receptors on
each cell were blocked. To resolve these alter-
natives, we examined subpopulations of migrat-
ing monocytes in normal subjects. We show by
various chemotaxis experiments using 10-,um-
thick polycarbonate filters that there is only one
subpopulation among all monocytes that is able
to migrate in vitro, and that most of these cells
respond to all three chemotactic stimuli
tested.
MATERIALS AND METHODS
Cell preparation. Blood was drawn from healthy
donors and heparinized. Mononuclear cells were iso-
lated by the method of Boyum (7). Blood was diluted
with an equal volume of Dulbecco phosphate-buffered
saline without calcium or magnesium (PBS) and 35 ml
of diluted blood was underlaid with 15 ml of lympho-
cyte separation medium (Bionetics, Rockville, Md.).
After centrifugation at 400 x g for 40 min at 20°C, the
interface cell layer was removed and washed twice
with Gey balanced salt solution containing 2% bovine
serum albumin (Cohn Fraction V) (Gey-BSA, Na-
tional Institutes of Health Media Unit, Bethesda,
Md.). The cell suspension contained 15 to 35% mono-
cytes, 65 to 85% lymphocytes, and less than 1% gran-
ulocytes. Viability was better than 99%, as measured
by trypan blue dye exclusion. Total and differential
counts were made for the final washed preparations.
Total leukocyte recovery was 10' to 3 X 10' cells per
ml of whole blood. Differential counts were made after
staining cell suspensions with euchrysin 3RX (Roboz
Surgical Instruments Co., Washington, D.C.) and ob-
servation with a fluorescence microscope. These num-
bers were used to standardize the cell number added
per chemotactic chamber.
Chemotactic factors. N-Formyl-methionyl-leu-
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cyl-phenylalanine-methylester (referred to as peptide)
was a generous gift of K. Ho (Eli Lilly & Co., Indian-
apolis, Ind.). The optimal concentration range for
chemotaxis was 10-7 to 10' M, as described (9). Hu-
man serum-derived complement component C5a was
prepared as described by Fernandez and Hugh (8)
with minor modifications. Briefly, 100 ml of serum was
incubated at 370C with 13 g of epsilon-aminocaproic
acid (Sigma Chemical Co., St. Louis, Mo.) and 100 mg
of zymosan (Mann Research Laboratories) which was
finely suspended in 2 ml of PBS; after 45 min of
incubation, it was processed as described (8). The total
preparation, about 260 ml after dialysis against start-
ing buffer, was added to a column of CM-Sepharose
C1 6B (Pharmacia Fine Chemicals, Inc., Piscataway,
N.J., 2.6-cm in diameter, 100 ml of gel) and eluted with
0.1 M ammonium formate buffer (pH 5), containing
0.5 mM ethylenediaminetetraacetic acid. Little or no
activity was found in the eluate. The column was then
washed with 250 ml of 0.3 M ammonium formate (pH
5), and the activity was eluted with 0.5 M buffer. The
pooled fractions were dialyzed against water, mem-
brane filtered (Millipore Corp., Bedford, Mass.), and
lyophilized. This material was reconstituted with 10
ml of PBS, and 5 ml was applied to a column of
Sephadex G-100 (2.5 by 80 cm) and eluted with 0.1 M
ammonium formate buffer, pH 5. Chemotactic activity
was detected in the 12,000-dalton region. The active
fractions were pooled, dialyzed against water, and
lyophilized. The material was solubilized in 10 ml of
PBS and stored in samples at -20'C. This preparation
is referred to as C5a. A dose-response is shown in Fig.
1. In some experiments, yeast-activated serum was
used. For this, baker's yeast was boiled in hot water
and washed with water four times. It was added at 1
mg/ml of serum and incubated at 37°C for 50 min in
the presence of epsilon-aminocaproic acid. The Fer-
nandez and Hugh procedure for activation was fol-
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lowed, but the acidified sample was dialyzed against
PBS and used for chemotaxis without fractionation.
Lymphocyte-derived chemotactic factors were pre-
pared by stimulation of leukocyte cultures made from
Ficoll-Hypaque separated cells as described previously
(2). Concanavalin A (Miles Laboratories, Inc., Elkhart,
Ind.) was used at a concentration in the culture me-
dium of 1 or 5 ,ug/ml. Homologous serum was added
to 0.5% concentration. Incubation time was 24 h. The
supernatants were put through 0.45-,tm filters, di-
alyzed against water, and lyophilized. The residue was
solubilized in PBS, applied to a Sephadex G 100 col-
umn and eluted with PBS. Peak chemotactic activity
was found in the 15,000-dalton region. Fractions were
pooled, stored at 4°C, and used as the standard prep-
aration of LDCF. The preparation showed some activ-
ity at a dilution of 1:80 and the dose-response curve
reached a plateau at 1:10. A 1:5 dilution was used to
give optimal chemotaxis.
Chemotaxis protocol. Monocyte chemotaxis was
assayed in blind well chambers (Neuroprobe Corp.,
Bethesda, Md.) with polycarbonate filters (5-Mum pores;
Nuclepore Corp., Pleasanton, Calif.). Chemotactic
agent in the indicated concentrations in Gey-BSA (200
,ul, total volume) was added to the lower chamber. The
upper chamber was filled with 0.3 ml of cell suspension
in Gey-BSA containing 8 x 104 monocytes. The cell
dose-response was linear over a 100-fold range (104 to
10" cells per chamber, Fig. 2). We chose a low cell
number to reduce the effort of counting and the num-
ber of cells needed. The chambers were incubated for
2 h in humidified air with 5% CO2 at 37°C. The cells
in the top chamber were removed, and the filters were
washed for 10 s in absolute methanol before staining
as described (10). Counting was done as previously
described (6). Each point was assayed in triplicate and
results were expressed as the mean ± the standard
error of the mean of the number of migrated cells per
20 oil fields. The percentage of migrating cells was
calculated as follows: the size of a high power oil field
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FIG. 1. Dose-response curve of human peripheral
monocytes to purified C5a. C5a in zymosan-activated
human serum was purified by CM-Sepharose Cl 6B
chromatography and Sephadex G- IX00 gel filtration.
NUMBER OF MONOCYTES IN UPPER CHAMBER
FIG. 2. Cell dose-response to peptide. The number
ofmonocytes added to the chemotaxis chamber in 300
tol of medium is shown on the abscissa. The two
inserts represent different experiments. The concen-
tration ofpeptide was 10" M.
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was calibrated; 20 counted fields represented 1/142 of
the whole filter area so that the counted number x
142 X 100 divided by the input monocyte number
equals the percent of migrating cells. The migrated
cells were more than 99% monocytes. Only very few
monocytes found on cover slips placed in the lower
chamber during incubation showed that the migrated
cells remained attached to the filter.
Deactivation procedure. Deactivation was car-
ried out by preincubation of the cells at a concentra-
tion of 2.6 x 105 monocytes per ml. The deactivating
concentration for the peptide was l07 M and for
activated serum was a dilution of 1:5. Incubation time
was 40 to 50 min at room temperature in Gey-BSA.
Control populations were preincubated under identical
conditions in Gey-BSA alone. After incubation, the
cells were centrifuged at 200 x g for 10 min and washed
3 times with Gey-BSA. After the last centrifugation,
the cells were suspended in 1 ml of medium for count-
ing. Differential counts and viable counts (by trypan
blue dye exclusion) were done, and the suspension was
then diluted to provide 8 x 104 monocytes per cham-
ber. The cell recovery was usually 70% with a viability
of over 95%.
Filter transfer. The filter transfer procedure was
as follows. When the cell layer on the top of the filter
was needed, the supernatant was carefully removed
with a pipette, the cell layer was washed once with
medium, and the filter was transferred to a new cham-
ber. When the top cell layer was not needed, it was
removed with a cotton swab. The new chamber was
filled with 195 p of medium or attractant dilution, and
the filter was carefully placed in it upside down or up
so as to avoid air bubbles. A 300-ELI portion of medium
was added to the top chamber. All manipulations were
carried out very quickly to prevent the filters from
drying out. Not more than three chambers were dis-
assembled for filter transfer at a time.
Sephadex G-10 separation of mononuclear
cells. Sephadex G-10 was swollen in Gey-BSA for 3 h.
Five ml of gel was added to a 35-ml syringe. All
manipulations were carried out at 4VC. Five to seven
ml of a cell suspension obtained by Ficoll-Hypaque
separation and containing 107 to 2 x 107 mononuclear
cells per ml was placed on top of the syringe columns.
The lymphocyte-rich eluant was collected in a 50-ml
polypropylene centrifuge tube. The column was
washed three times with 5 ml of Gey-BSA, and the
washing fluids were combined with the first eluant.
The gel was then transferred into a 50-ml centrifuge
tube and suspended in 40 ml of medium. After the
tube was gently shaken, it was centrifuged for 15 s at
100 x g. The supernatant was filtered through loosely
packed siliconized glass wool and centrifuged. The
cells were suspended in 1 or 2 ml of medium and
counted.
RESULTS
Influence of lymphocyte-monocyte ratio.
The cell dose-response curve (Fig. 2) shows that
the number of migrated cells is directly propor-
tional to the number of monocytes in the top
chamber. Since donor variation with respect to
the monocyte/lymphocyte ratio is in the range
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of 15 to 35% monocytes to 65 to 85% lymphocytes
in the Ficoll-Hypaque separated fraction, we
determined whether this ratio had any influence
on the migration. A cell suspension containing
24% monocytes and 76% lymphocytes was frac-
tionated on Sephadex G-10. The cell suspension
which was separated from the beads by shaking
was composed of 64% monocytes and 36% lym-
phocytes with a viability of over 99%. Monocyte
recovery was about 40%. The dose-responses of
this and the original cell suspension to chemo-
tactic peptide were compared (Fig. 3); there was
no significant difference in the response.
In the remainder of this paper, we discuss the
results which show that human monocytes can
be selectively deactivated to different attract-
ants; this implies different chemotaxin receptors.
Then, after examining a series of different ex-
perimental approaches, we conclude that most
of the responding monocytes have receptors for
all three of the chemotaxins tested.
Selective deactivation by preincubation.
Mononuclear cells were incubated in diluted ac-
tivated serum, in a chemotactic peptide solution,
or in medium as a control. After extensive wash-
ing, the cells were counted, adjusted to equal
monocyte numbers, and assayed for their re-
sponses to activated serum and peptide (Table
1). The response of the cells to the deactivating
chemotaxin was suppressed, whereas the re-
sponse to the new chemotaxin was not altered.
This was true for both deactivating agents. The
deactivation was therefore chemotaxin specific
and migration to other chemotaxins was not
inhibited.
Selective migration in the presence of
deactivating concentrations of chemotax-
- Ficoll- Hypaque cells
---Monocytes after G10
90
cr0 ,, \\zoI
10-10 10 8 io4
MOLAR CONCENTRATION OF PEPTIDE
FIG. 3. Comparison of the dose-response curves of
Ficoll-Hypaque cells and a Sephadex G-1O enriched
monocyte suspension. The two cell suspensions were
adjusted to the same monocyte number per ml. The
chemoattractant was peptide.
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ins. An experiment similar to the above was
done with a three-attractant system. Cells were
suspended in medium containing different
chemotaxins in deactivating concentrations.
These suspensions were placed in the top cham-
bers. The bottom chambers were filled with
chemotaxin solutions as shown in Table 2; again,
the chemotaxin response was specific. The at-
tractants in the mixture of all three had the
same concentrations as when used alone. Little
or no response was observed to attractant in the
lower chamber if the same attractant was pres-
ent in the upper one (Table 2, italicized data).
However, if the attractants in the top and bot-
tom chambers were different, the monocytes
responded to the stimulus by migration. With a
mixture of all three attractants in the top cham-
ber, there was little or no migration to any
stimulus in the bottom (Table 2, bottom line).
This shows that these three attractants are spe-
cifically recognized by the cells and that it is
TABLE 1. Specific deactivation of monocytes
Mean no.
Cells preincubated of mono-
for 40 min at 220C Attractant cytes per
in"I 20 oil fields
± SEMh
Medium Activated serum' 90 ± 10
Peptide 115 ± 15
Peptide (10-7 M) Activated serum 110 ± 15
Peptide 35 ± 5
Activated serum Activated serum 30 + 5
(1:5 dilution) Peptide 150 ± 10
" After preincubation, the cells were washed three
times with medium and then assayed.
bSEM, Standard error of the mean.
'Yeast-activated human serum; dilution 1:40.
possible to desensitize specifically to one attract-
ant, leaving responsiveness to other attractants
intact. At the desensitizing concentrations
shown, capacity of the cells for movement was
not affected.
Evidence for different chemotaxin recep-
tors on the same monocyte. The previous
experiments led to the questions of were differ-
ent populations responding to different attract-
ants, or was one population capable of respond-
ing to all of the three stimuli used? To evaluate
these questions, we set up an experiment to test
for migration of additional cells after a standard
chemotaxis incubation. Cells in the first run
migrated to medium, peptide, or C5a (Fig. 4).
After the 2-h incubation period, the superna-
tants in the top chambers were carefully re-
moved and the filter top surfaces were gently
rinsed so as not to remove adherent cells. The
filters were then placed in new chambers con-
taining medium or different attractants in the
bottom wells. Medium was added to the top
well. The chambers were incubated for 2 h to
determine if additional cells migrated during this
period. Results for the sequences medium-pep-
tide or medium-C5a were the same as for pep-
tide-medium or C5a-medium, showing that the
cells remained viable during the transfer and
were capable of responding to a chemotactic
stimulus after a first incubation period (Fig. 4).
No increase in numbers of migrated cells was
observed when the cells migrated towards pep-
tide or C5a in the first run and were then tested
for response to either stimulus in the second run.
This lack of additional migration suggests that
there is predominantly a single population of
cells capable of being attracted by either peptide
TABLE 2. Selective migration ofhuman monocytes
Mean no. of migrated monocytes ± SEMW with the following attractant in lower chamber:
Attractant in upper cham-
ber" LDCF + C5a +Medium LDCF' C5a" Peptide" Peptide'
Medium 65 ± 7 266 ± 57 184 ± 20 247 ± 47 252 ± 52
LDCF 1:55 85 ± 10 75 ± 5 160 ± 15 170 ± 35 270 ± 30
C5a 20 ± 10 190 ± 20 40± 15 300 ± 20 340 ± 20
Peptide 10 ± 5 75 ± 25" 240 ± 10 35 ± 5 340 ± 15
LDCF + C5a + Peptide 10 ± 5 45 ± 20 10 ± 5 35 ± 15 40 ± 5
"The cells were mixed with the indicated attractants and placed into the upper chamber.
SEM, Standard error of the mean. For each row in the table, the response with different attractants in
upper and lower chamber was significantly greater than the response with the same attractants in both
chambers.
'A 1:5 dilution of stock solution in both chambers.
"A 1:50 dilution in upper chamber; 1:500 dilution in lower chamber.
"A 10-7 M concentration in upper chamber; 10'8 M concentration in lower chamber.
fThe concentration of single attractants in the mixture was the same as when used alone.
-'See text for preparation of stock solution dilutions.
h The low response to LDCF when peptide is on top was observed in two other experiments and has not been
explained.
INFECT. IMMUN.
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Attractants Mean number of migrated
monocytes per
First run Second run 20 oil fields ± SEM
Medium Medium 20 ± 5
Peptide 70 ± 5
C5a 85± 10
Peptide Medium 75 ± 10
Peptide 85± 10
C5a 90± 5
C5a Medium 90±10
Peptide 85 ± 10
C5a 85± 30
C5a prep. 1:500 Peptide 10-'M
FIG. 4. Absence of cellpopulations with specificity
for only one chemotaxin. A normal chemotaxis exper-
iment was performed during the first run with the
indicated attractants. The filters with cells remaining
on both surfaces were then transferred to new cham-
bers with the indicated chemotaxins, incubated for 2
h, stained, and counted to determine if the presence
of different chemotaxins in the second run increased
the number of migrated cells. SEM, Standard error
of the mean.
or C5a and thus having receptors for both.
To obtain direct evidence for the presence of
multiple receptors on the same cell, we set up
the following experiment. During the first 2-h
incubation period the cells were tested for re-
sponse to activated serum or peptide in the usual
way (Table 3). Supernatant and cells were then
removed from the top chamber. Control me-
dium, activated serum, or peptide was then
placed in the top chambers in the same concen-
trations as used for the first period. The cells
which migrated to the bottom of the filter in
response to the first stimulus now responded to
the second stimulus by upward migration to the
top of the filter. After the second incubation
period, the cells remaining on the filter bottom
were counted. These numbers are presented in
Table 3; reduction in number compared to the
medium response means back migration. Cells
selected by response to one attractant were ca-
pable of back migration to a different attractant
(see italicized data in Table 3). In the first row
of the table, cells selected by response to acti-
vated serum migrated back to peptide and vice
versa for the second row. Similar results were
obtained for a three attractant system (LDCF,
peptide, and C5a).
Reduction in cell number on the bottom of
the filter is, of course, an indirect measure of
back migration, and it is possible that cells were
simply falling off the filter into the bottom well.
However, as noted above, migrated monocytes
did not fall off filters onto cover slips placed in
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the bottom wells. A second migratory response
was also shown directly by removing the filter
after the first incubation and placing it upside
down in a new chamber with a new attractant.
The migrated cells, now on the top of the filter,
migrated a second time and were counted on the
bottom of the filter after the second incubation.
Quantitation. The previous experiments
demonstrate in a qualitative way that there is
only one population ofmigrating monocytes that
responds to the stimuli used. The results are
qualitative because they may be affected by
many factors such as diffusion of chemotaxins,
aging of cells, or exhaustion of the motility ap-
paratus. To get quantitative information, we
arranged an experiment with all possible com-
binations of3 attractants in a normal chemotaxis
assay. Seven different attractant combinations
are possible with respect to 3 attractants and the
corresponding receptors on the cells (Table 4).
With the attractant combinations indicated and
counting the numbers of cells attracted by these
combinations, one can set up seven equations
for seven unknowns, as outlined in the table
(e.g., x + u + v + t = 130). It is apparent that
the number of cells responding to a mixture of
all three attractants is not much greater than
the number responding to a single attractant.
Thus, most of the cells have receptors for the
three attractants used; t = 75%. The results from
the solutions of the equations are shown in the
rightmost column of the table. The fact that the
total percentage exceeds 100 is attributable to
the standard errors of the counted numbers.
TABLE 3. Evidence for more than one receptor for
chemoattractants on a single cell
Mean no. of migrated monocytes per
20 oil fields ± SEM with the following
attractants in upper chamber for sec-
Attractant for ond run:"
first run in lower
chamber Activated
serum (1: Peptide
Medium 40 dilu- (10-' M)
tion)
Yeast-activated 200 ± 10 200 ± 50 90 ± 5
serum (1:40
dilution)
Peptide (10' 320 + 20 90 + 15 140 + 20b
M)
SEM, Standard error of the mean.b The response to the same attractant is possible
because the attractant in the bottom chamber may be
diluted by diffusion into the top chamber or destroyed
by migrated cells (4, 12) during the first period. Addi-
tion of attractant to the top chamber thus creates a
concentration gradient in the direction of the top
chamber.
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TABLE 4. Estimation of the fraction of migrating cells with a peculiar set of receptors
No. of cells Observed no. Calculated
Possible receptor combination on a with recep- No. of cells migrating to correspond- of cells mi- values for
single cell tor combi- ing attractant combination grating column 2'
nation
C5ab x x+u+w+t 130C 10
LDCF y y+u+v+t 150 5
Peptide z z+v+w+t 130 25
LDCF+C5a u x+y+u+v+w+t 130 10
LDCF + peptide v y+z+u+v+w+t 170 0
C5a + peptide w x+z+u+v+w+t 160 0
C5a+LDCF+peptide t x+y+z+u+v+w+t 180 75
"As percentage of total cells migrating to the combinations of all three attractants (180). Due to the standard
errors, the percentages can vary by ±15%.b Optimal concentrations were used: C5a, 1:500; LDCF, 1:5; peptide, 10' M.
' Mean number of monocytes per 20 oil fields.
DISCUSSION
Only 20 to 40% of human peripheral blood
monocytes responded by migration to chemotac-
tic stimuli. These findings raised two questions
that we attempted to answer. First, do the re-
sponsive monocytes represent a distinct subpop-
ulation among the total blood monocytes in
vivo? Second, are there migrating monocytes
with different chemotaxin receptors or combi-
nations of receptors on their surfaces? An ap-
proach to the first question is to consider the
possibility that the limit in the number of mi-
grating monocytes is not due to a subpopulation,
but that the population is uniform and the lim-
itation is due to an aspect of the in vitro system,
such as restriction for movement by small pore
diameter or low pore density, cell crowding on
the filter, inadequate time for migration, disap-
pearance of chemotaxin gradient, or loss of cel-
lular capacity to respond. The in vitro system
was therefore analyzed in several ways. It was
shown that the number of migrated cells was
always proportional to the number ofmonocytes
in the upper chamber over at least a 100-fold
range (Fig. 2) and thus, over this range, migra-
tion was not limited by cell crowding. Further-
more, the result was unaffected by the propor-
tion of lymphocytes in the cell suspension (Fig.
3). This is in agreement with two studies in the
literature (1, 15). The possibility that the num-
ber of migrating cells was restricted by the pore
density on the filter was ruled out by our finding
that there was no significant increase in the
number of cells migrating through filters with
twice the usual number of pores per unit area
(unpublished data). We also showed that the
limit in the number of migrated cells was not
due to selection of a population responsive to
only one chemoattractant (the remaining cells
being responsive to another attractant) since in
the filter transfer experiment (Fig. 4), a signifi-
cant number of cells with the ability to migrate
to another attractant could not be detected. This
also rules out duration of incubation or disap-
pearance of chemotaxin gradient as limiting fac-
tors. Furthermore, the medium control shows
that the cells could still migrate after the first
incubation period and therefore the limit in mi-
gration numbers was not due to loss of migratory
capacity during the experiment. These studies
provide the most compelling evidence to date
that the monocytes capable of migrating to
chemotaxins represent a subpopulation of the
total blood monocytes.
The analysis of monocyte receptor specificity
was made with three attractants that may have
importance in immune reactions: LDCF, made
by stimulation with concanavalin A of human
lymphocytes; C5a from human blood, purified
by a procedure analogous to that described by
Fernandez and Hugli (8); and a synthetic pep-
tide, N-formyl-methionyl-leucyl-phenylalanine-
methylester. Small peptides are believed to be
the attractants released by bacteria (3, 5). The
conclusions drawn from this part of the study
are that the three attractants are recognized by
different receptors and that the great majority
of responding cells have all three of these recep-
tors. Evidence for receptor specificity was based
on deactivation studies such as the one showing
the preincubation of cells with one attractant
selectively inhibited the subsequent response to
that attractant, whereas the response to a differ-
ent attractant remained intact (Table 1). These
findings are in agreement with results for other
migrating cells, like rabbit neutrophils (16), hu-
man peripheral blood neutrophils (11), or eosin-
ophils (17).
Evidence for different receptor specificities on
the same cell was obtained directly from the
back-migration experiment shown in Table 3.
The essence of this experiment is that a specified
cell population was first selected by its response
to one particular attractant. This cell population
958 FALK AND LEONARD INFECT. IMMUN.
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HUMAN MONOCYTE CHEMOTAXIS 959
was then used for the next step, in which it was
determined whether the cells could migrate back
upwards toward a different attractant. Since the
cells migrated back, we concluded that the same
cells that responded to one stimulus could re-
spond to a second or third different stimulus and
therefore must have at least three different re-
ceptor specificities. The simplest, albeit indirect,
experiment to show that there are different re-
ceptor specificities on the same cell is shown in
Table 4. With all the possible combinations of 3
attractants, one should expect an addition be-
havior in the case of single receptors on one cell
and the same numbers in the case of multiple
receptors. Table 4 shows that at least 75% of the
migrating cells must have receptors for all 3
attractants.
Restriction of chemotactic responsiveness in
vitro to a subpopulation ofblood monocytes may
also occur in vivo. The ability to migrate may
represent one ofseveral maturational stage qual-
ities exhibited by monocytes on their way from
the bone marrow to become effector macro-
phages in normal tissues and in sites of inflam-
mation. Our findings permit us to separate mon-
ocytes on a preparative scale into two popula-
tions on the basis of their chemotactic response
and to determine if there are morphological,
biochemical, or functional differences in these
two populations.
The defect in chemotaxis of monocytes from
cancer patients can be explained either by the
formation of subpopulations of migrating cells
with missing or blocked receptors, by a change
in dose-response, or by a decrease in the re-
sponding cell number. A clinical study to answer
these questions will require a determination of
(i) the number of responding cells, (ii) the dis-
tribution of receptors among the cells, and (iii)
the dose-responses for various attractants.
These studies are in progress.
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